We have previously reported a dystrophinrelated locus (DMDL for Duchenne muscular dystrophy-like) on human chromosome 6 that maps close to the dy mutation on mouse chromosome 10. Here we show that this gene is expressed in a wide range of tissues at varying levels. The transcript is particularly abundant in several human fetal tissues, including heart, placenta, and intestine. Studies with antisera raised against a DMDL fusion protein identify a 400,000 Mr protein in all mouse tissues tested, including those of mdx and dy mice. Unlike the dystrophin gene, the DMDL gene transcript is not differentially spliced at the 3' end in either fetal muscle or brain.
ABSTRACT
We have previously reported a dystrophinrelated locus (DMDL for Duchenne muscular dystrophy-like) on human chromosome 6 that maps close to the dy mutation on mouse chromosome 10. Here we show that this gene is expressed in a wide range of tissues at varying levels. The transcript is particularly abundant in several human fetal tissues, including heart, placenta, and intestine. Studies with antisera raised against a DMDL fusion protein identify a 400,000 Mr protein in all mouse tissues tested, including those of mdx and dy mice. Unlike the dystrophin gene, the DMDL gene transcript is not differentially spliced at the 3' end in either fetal muscle or brain.
Dystrophin has been identified as the protein product defective in Duchenne muscular dystrophy (DMD); however, very little is known about its precise function (1) (2) (3) . Sequence comparisons have revealed features in common with cytoskeletal proteins. The amino-terminal region of dystrophin shows homology to the actin binding region of a-actinin (4, 5) and the central rod domain shows structural similarities to the triple helical configuration of spectrin (6) . In contrast, the carboxyl-terminal domain of 420 amino acids does not show homology to any previously characterized proteins. This latter domain is thought to be important in the integration of dystrophin into a glycoprotein complex localized at the muscle membrane surface (7, 8) . The carboxyl-terminal region of the gene is differentially spliced in muscle and brain, which suggests the production of isoforms with differing interactions with membrane proteins (9) . In addition, this region of dystrophin is important for the correct functioning of the molecule in vivo as deletions covering this domain result in DMD rather than the milder Becker muscular dystrophy (10) (11) (12) (13) .
Recently, we demonstrated the existence of an mRNA in human fetal muscle that shares a high degree of sequence homology with the carboxyl-terminal region of dystrophin (14) . The gene encoding this transcript is localized to human chromosome 6 and the locus has been designated DMDL for DMD-like in Human Gene Mapping 10 (15). The DMDL gene shares structural similarities with dystrophin: the transcript is large, 13 kilobases (kb), and is multiexonic with a similar distribution of 3' exons and introns.
Although no human disease has yet been attributed to mutations at the DMDL locus, the mouse homologue of this gene, designated Dmdl, has been shown to be syntenic with the dy (dystrophia muscularis) locus on mouse chromosome 10 (16) . The dy mutation is recessive and results in a severe neuromuscular disease in the mouse in which skeletal muscle shows degenerative changes (17) . These observations suggest that the Dmdl gene may be a candidate for the dy mutation.
In this paper, we present the tissue distribution of the DMDL transcript in humans and compare this distribution with the presence of a 400,000 Mr protein in mouse tissues. We also investigate the occurrence ofthe DMDL polypeptide in liver and muscle of mice with mutations in the dy locus.
EXPERIMENTAL METHODS
RNA Preparation and Northern and Slot Blot Analyses. RNA was isolated from homogenized tissues by precipitation in 3 M LiCI/6 M urea at 40C and stored in ethanol at -700C.
Northern blots were prepared by denaturing RNA in formamide/formaldehyde at 650C prior to electrophoresis in a 1% agarose gel in 20 mM Mops buffer (pH 7.0) and 2.2 M formaldehyde and transfer to nylon membranes (Pall Biodyne; ref. 18 ). The blots were hybridized with 32P-labeled DNA fragments and then washed three times for 20 min each in 50 mM sodium phosphate, pH 7.5/1% SDS at 650C. The DMDL probes were not found to cross-hybridize with dystrophin mRNA under these conditions. Slot blot analysis involved denaturation of RNA in glyoxal (19) and direct transfer to a membrane using a slot blot apparatus (Schleicher & Schuell) as described (20 DNA Analysis. High molecular weight DNA from various animal species was prepared as previously described (22) or purchased from IBI. DNAs were digested with restriction enzymes, electrophoresed in 0.8% agarose gels, and transferred to nylon membranes (Hybond N; Amersham). The blots were hybridized in a 50% formamide mix at 42TC (22) and finally washed in 3 x SSC/0.1% SDS at 65TC for 30-60 min prior to exposure to Fuji x-ray film at -70TC for 1-7 days. In the case of hybridization to nematode DNA (see Fig. 4C ), the blot was incubated at 240C rather than 420C and was washed twice for 15 min each in 3.4 x SSC/0. 1% SDS at 600C. Oligonucleotide hybridization was performed in 6x SSC, lOx Denhardt's solution, and 50 ,g of denatured, sonicated salmon sperm DNA per ml at 63°C for 2 hr. The blot was then washed in 6x SSC/0.1% SDS at 63°C for 10 min prior to exposure to x-ray film.
DNA probes were prepared using commercially supplied random-primed labeling kits (Amersham and Boehringer Mannheim) following the manufacturers' instructions. Oligonucleotides were 5' end-labeled following standard procedures (18) . cloned into the Sma I site of the expression vector pEX2 and introduced into Escherichia coli POP2136 cells. Induction and purification of the ,B-galactosidase fusion protein and immunization of BALB/c mice were performed as described (23) . Tissue samples were homogenized in boiling extraction buffer (4 ml/g) containing 10%6 SDS and the extracts were subjected to SDS/PAGE followed by Western transfer (23 (14) . The DMDL transcript migrates slightly ahead of dystrophin on Northern blots (Fig. 1) and shows ubiquitous tissue distribution (Fig. 2) . The DMDL and dystrophin transcripts are expressed at relatively low levels in brain (results not shown) and, in contrast to dystrophin, skeletal muscle is not the major site of DMDL expression (Fig. 2A) ; dystrophin is expressed predominantly in muscle and neuronal cells (2, 27) .
DMDL transcripts are detected at highest levels in placenta during gestation and at term (Fig. 2B) . Furthermore, DMDL mRNA is found in a broad range of fetal and adult tissues, including liver, intestine (smooth muscle), skeletal muscle, testis, and kidney (fetal testis and kidney were not tested; Fig. 2 ). The DMDL transcripts are more abundant in certain fetal tissues such as placenta, skeletal muscle, intestine, and heart than in the corresponding mature tissue; in particular, expression is high in fetal heart but almost undetectable in adult heart. Among adult tissues, DMDL mRNA levels are highest in kidney, testis, and liver.
The pattern of hybridization shown by the actin probe was as expected (Fig. 2) . This probe contains untranslated sequence that hybridizes specifically with human skeletal a-actins and coding sequences that are conserved among skeletal, cardiac, and smooth muscle actins and nonmuscle actins (25) .
Differential splicing has been reported to occur in the carboxyl-terminal end of the dystrophin transcript in fetal tissue and it has been suggested that this yields protein isoforms that may interact differently with membrane proteins (9) . We screened the corresponding region of the DMDL transcript for alternative splicing in muscle in order to determine if isoforms are also a feature. The PCR was used to amplify overlapping 5' and 3' segments of Bfm3, and the products were compared with those obtained from the corresponding region of the dystrophin transcripts (Fig. 3) . The alternatively spliced products previously described for the 3' end of dystrophin in fetal muscle are clearly seen but only the single fragments predicted for each amplified segment of the DMDL transcript are found. Similar results were observed after amplification of brain RNA (results not shown). The PCR analysis also shows that differential splicing within the most 3' region of dystrophin is developmentally expressed. Two high molecular weight PCR products are seen after amplification of fetal muscle RNA, whereas only one ofthese products is amplified from adult muscle RNA within region D3' (Fig. 3) . In the case of the 5' region of Bfm3 (BS'; Fig. 3) , the low molecular weight fragment amplified from adult muscle RNA would appear to be an artefact because it did not hybridize with Bfm3. No evidence of alternative splicing was found when the entire coding region of Bfm3 was amplified from fetal muscle cDNA (results not shown).
The degree to which the 3'-end coding sequence of the DMDL gene is conserved among various vertebrate species was examined using a 1.9-kb EcoRI-HindIII fragment of Bfm3 that contains at least seven 3' exons (14) . Fig. 4 shows that this region of the DMDL gene is very highly conserved since multiple homologous fragments are observed in all of the species tested, including the chicken, and that this homology extends to the nematode. In the case of Fig. 4 A  and (Fig. SA) , which is equivalent in size to dystrophin (Fig. 5B). A comparison of Fig. 5 A and B indicates that the 400,000 Mr protein is produced in mdx mouse muscle, which shows no detectable dystrophin. Therefore, a survey of tissue distribution of the 400,000 Mr protein was made in the mdx mouse in order to avoid problems of interpretation associated with cross-reactivity between DMDL antibodies and dystrophin.
The 400,000 Mr protein is ubiquitously expressed in the adult mdx mouse (Fig. SC) muscle and liver; the latter tissue was tested because dystrophin is not expressed in liver (Fig. 5D2) . The dy2J mouse produces approximately the same amounts of the 400,000 Mr protein in both tissues as the mdx mouse ( Fig. 5 A and DI) ; the staining in dy's muscle, however, may be complicated by cross-reactivity between the antibodies and dystrophin. The dy2J mutation is one of at least fiye mutant alleles at the dy locus and gives rise to the less severe phenotype compared with dy mice (28) . The analysis of the dy mouse shows no significant difference between the levels of expression of the 400,000 Mr protein in liver (Fig. 5DI) (29, 30) . In this disorder, initial analysis of the expression of cardiac 8-myosin using immunohistochemical techniques failed to reveal changes in patients (31, 32) . A detailed comparison of the sequence of the wild-type mouse DMDL gene with that of the dy mouse will be needed to determine the involvement, if any, of the DMDL protein in the dy phenotype.
Recently, dystrophin-related proteins of 400,000 Mr have been detected using polyclonal antibodies against dystrophin (33, 34) and the DMDL gene product (35) . In the case of dystrophin antisera, immunolocalization studies show staining in the pia mater of mdx mouse brain (33) and the neuromuscularjunctions of DMD patients and mdx mice (34) . These studies compare with the sarcolemma localization determined for dystrophin in human and mouse muscle (36, 37) 
